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Abstract
The placement of central venous catheters (CVC) is a common medical procedure 
and adjunct to current medical therapy. With millions of CVC placed yearly in the 
United States, complications occur. It is important to be aware of the potential imme-
diate and long term complications associated with this procedure. In this chapter, 
a representative case of retained CVC guidewire is presented. Provider experi-
ence, appropriate patient selection and insertion technique can minimize the risk 
of immediate complication in most cases. A brief discussion of CVC complications 
with emphasis on guidewire malfunction is presented along with management and 
retrieval options.
Keywords: retained guidewire, central venous catheter, catheter complications, bedside 
procedures, J wire, guidewire fracture, intravascular foreign body
1. Introduction
With more than 5 million central lines placed in the United States every year, complications 
are anticipated [1–4]. The most common immediate complications of central venous catheter-
ization (CVC) include pneumothorax (incidence of 0.5–1.5%), arterial puncture (0.5–3.7%), 
and cardiac ectopy (0.9%) [1, 5, 6]. Retained guide wire is a recognized but rare complication 
during insertion of CVC. The estimated incidence is 0.05–0.1% during CVC insertion [7, 8]. 
Causes of retention include guide wire looping, entrapment, wedging within catheter and 
fracture during insertion [9–11]. While retained guide wire is a rare complication, it is entirely 
preventable except in cases of catastrophic equipment failure and is considered an unaccept-
able occurrence by physicians.
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Vignette
A 69 year old female presents with pneumonia and sepsis. She is hypotensive and unrespon-
sive to multiple fluid challenges. The placement of a CVC is necessary for norepinephrine 
infusion therapy. She has a past medical history of hypertension, diabetes mellitus (type II), 
and chronic obstructive pulmonary disease. Her past surgical is significant for laparoscopic 
cholecystectomy and Cesarean section. She denies a history of head/neck surgery or prior 
central venous instrumentation.
After obtaining consent, a right internal jugular (IJ) CVC is placed using ultrasound guidance. 
After gaining venous access, the guide wire is threaded. It initially passes easily but resistance 
is met at approximately 10 cm. An attempt is made to withdraw the guide wire, however sig-
nificant resistance is met. After multiple attempts to withdraw and advance the guide wire, 
there is a sudden change in resistance and the guide wire is easily advanced. The remainder 
of the procedure is completed using the modified Seldinger technique and a triple lumen 
catheter is placed. All ports easily draw blood and flush with saline (Figure 1).
A post procedure chest X-ray is obtained. The tip of the catheter terminates in the mid-
superior vena cava (SVC) and a linear hyperdensity within the right atrium is noted. This 
is approximately 8 cm in length and consistent with retained guide wire. You inspect the 
procedural guide wire and note that the distal end does not have its characteristic “J” bend.
Figure 1. Chest X-ray revealing a retained guide wire (arrow).
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3. Discussion
When inserting a CVC, it is essential that the provider is experienced and has been appro-
priately trained, supervised, and privileged to perform the procedure. If the clinical scenario 
allows, informed consent should be obtained. An appropriate insertion site should then be 
selected. The modified Seldinger technique is utilized for catheter placement. If an IJ or sub-
clavian (SC) catheter is inserted, chest X-ray is performed to confirm placement location and 
ensure no pneumothorax has developed [2, 6, 12–16].
3.1. Indications and catheters
CVC are an important component of medical care. They provide temporary short-term or 
long-term vascular access and are used for hematologic sampling and monitoring, long-
term antibiotic administrations, hemodialysis, and the delivery of caustic therapeutics such 
as vasopressors, total parenteral nutrition (TPN), and chemotherapy. During insertion and 
when not in use, these catheters are flushed to maintain patency. Flushes are usually a sterile 
saline or heparin saline solution which is injected to fill the catheter. If an institution utilizes 
heparin saline for flushes, care should be exercised to identify patients with contraindications 
to heparin such as history of hypersensitivity reaction, and heparin-induced thrombocyto-
penia (HIT) [17–19]. There are many devices available for central venous access but they are 
generally composed of silicone or polyurethane which allows for relative stiffness at room 
temperature and a softened state at body temperature [6, 11]. CVC can be broadly categorized 
into non-tunneled, tunneled, and implantable with ports.
Of these, non-tunneled CVC are the most frequently inserted. They are typically placed at 
bedside for short-term therapy (1–4 weeks) and in patients with significant physiologic dis-
tress [12]. The most frequent entry sites are the internal jugular (IJ), subclavian (SC), and 
femoral veins. Peripherally inserted central catheters (PICC) are similar to non-tunneled CVC. 
They are non-tunneled catheters placed at bedside, although generally in a more elective fash-
ion. They are inserted through a peripheral arm or leg vein and advanced until the tip lies in 
the SVC. They are small-bore catheters that usually enter the system in the brachial, antecubi-
tal or long saphenous veins. They have the benefit of comfortable positioning for the patient 
and have lower reported infection rates than IJ, SC, or femoral catheters. PICCs have a smaller 
total diameter with only 1–2 lumens and slower maximum infusion rates [20]. Midline cath-
eters are placed in the same entry sites as PICCs but terminate in the axillary vein. While still 
considered a short-term device, PICC and midline catheters are often maintained longer than 
a non-tunneled CVC due to their lower infection rates. In the literature, there is emphasis that 
these should still be considered a short-term catheter and to cautiously maintain them for >4 
weeks [20].
Tunneled CVC are placed in a procedure or operating room utilizing fluoroscopy for visu-
alized insertion. These catheters are tunneled through subcutaneous tissue and contain a 
Dacron cuff which causes fixation. The combination of tunneling and cuffed fixation creates 
physical barriers to infection, reducing infection rates and allowing for long term use of these 
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catheters. Implanted ports are also long-term devices placed in the operating room. They con-
sist of a catheter and diaphragm which is accessed via cutaneous puncture. Inserted subcuta-
neously, ports are typically placed in upper anterior chest wall though an IJ or SC approach 
[12]. Once inserted, they have no externalized components allowing for the lowest infection 
rates amongst CVC [21]. For the purposes of this paper, we will briefly review relevant anat-
omy and insertion technique for non-tunneled IJ, SC, and femoral catheters. PICC and mid-
line catheters are not addressed here as most hospitals have a dedicated team of providers 
who perform these insertions [22].
3.1.1. IJ catheterization
After selecting an appropriate access site, the care team should don hat and masks. The pro-
vider will then wash his/her hands and dress in sterile gown and gloves. The area is prepped 
and draped in normal sterile fashion with chlorhexidine solution. During the prep, the pro-
vider should examine the contents of the sterile central line insertion kit. Each hospital has its 
own standard CVC kit and it is important to be familiar with the equipment prior to proceed-
ing. The catheter lumens are then flushed with sterile saline or heparin saline and compatibil-
ity of the needle, guidewire, and catheter should be confirmed. The contents of the kit should 
be organized in a fashion that allows for easy transition from one portion of the procedure to 
the next.
After sterile draping, the desired cannulation site is infiltrated with local anesthetic. If utiliz-
ing ultrasound, this should also be sterilely draped at this time. The provider will position 
themselves at the head of the bed with ultrasound in the nondominant hand. The patient is 
then placed in Trendelenburg position and the head rotated 30–45° away from the access 
side to allow access to the neck. Additional rotation of the head to the contralateral side does 
not aide the provider as it brings the sternocleidomastoid muscle into an anterior position 
over the IJ and increases the anterior-posterior overlap of the IJ with the carotid artery [2]. 
Therefore, only as much rotation as is needed to gain access to the neck is utilized.
Next, IJ and carotid artery are inspected sonographically. It is important to be familiar with 
regional anatomy and anatomic landmarks. For the IJ approach, the landmarks are the sternal 
and clavicular muscle heads of the sternocleidomastoid, and the clavicle. These borders create 
a triangle known as Sédillot’s triangle. The carotid and IJ are identified slightly superior to the 
apex of the triangle. IJ is typically anterior/lateral and is easily compressed with ultrasound 
probe. For patients with difficult to identify IJ or complex anatomy, color doppler mode or 
duplex mode can be utilized for identification. Once identified, the large-caliber introducer 
needle is inserted through the skin at the apex of the triangle with approximately a 20–30° 
angle. While maintaining aspiration, it is advanced under direct visualization into the IJ. This 
is typically encountered 0.5 cm below the skin with the needle along an axis towards the 
ipsilateral nipple [2].
Once venous access is obtained, the US is set aside and the syringe is removed, taking care 
not to disturb the needle. With the J end of the guide-wire directed towards the midline, it 
is passed through the needle. It should thread smoothly and advance without resistance. If 
cardiac arrhythmia or ectopy is noted, immediately withdrawal the wire until it ceases. The 
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needle is then removed, maintaining continuous control of the wire. A stab incision is made 
at the insertion site. A dilator is then passed over the wire, dilating the subcutaneous tissue. 
This is removed and the catheter is threaded over the wire. At this point, it is necessary to 
back feed the wire proximally until control is regained from the distal aspect of the catheter 
port. Once obtaining control of the wire, the catheter is inserted over the wire into the ves-
sel. The wire is then removed and blood return is confirmed from each port with a follow-
ing flush. Ultrasound can be utilized to confirm placement within the IJ and examine the 
lung fields for violation. The catheter is then secured in place and a sterile occlusive dressing 
is applied. Prior to removal of any equipment, a final sharps count and examination of the 
guidewire should be performed to ensure complete retrieval of guidewire with J-shaped tip 
and no sharps were misplaced. An upright chest X-ray is then obtained to confirm placement 
and verify no pneumo or hemothorax.
3.1.2. SC catheterization
A similar method is utilized for a SC approach [2, 12, 14–16]. A small shoulder roll may be 
placed between the shoulder blades to allow the shoulders to drop backwards. This maneuver 
exposes the necessary anatomy and brings the SC ventrally. If the shoulder roll is too large, 
the vein can collapse between the first rib and clavicle [1, 2]. Anatomic landmarks for SC 
access are the sternal notch, and the junction of the middle and medial third of the clavicle, 
near the deltopectoral groove. The provider will position him/herself on the side that is to be 
accessed. Following shoulder roll placement, the head is rotated slightly away from the side 
of insertion and the patient is placed into Trendelenburg position. The provider will place 
the nondominant index finger in the sternal notch and thumb on the clavicle above the delto-
pectoral groove. If accessing the right SC a right handed provider will turn their hips slightly 
towards the feet, if accessing the left their hips will be turned slightly towards the head; this 
allows comfortable positioning throughout the procedure. Local anesthetic is infiltrated and 
the access needle is inserted approximately 1–2 cm inferior and lateral to the junction of the 
middle and medial thirds of the clavicle. With continuous aspiration, the needle is directed 
medially and slightly cephalad in an axis towards the sternal notch and parallel to the floor. 
The needle may be “walked down” the clavicle if desired and passed beneath the clavicle with 
gentle downward pressure applied with the nondominant hand and advanced until venous 
blood is withdrawn. The syringe is then removed and the guidewire introduced with the J 
end directed caudally. The needle is removed; skin incised, and subcutaneus tract dilated. The 
catheter is then inserted over the guidewire again taking care to maintain continuous control 
of the wire throughout. The wire is removed, blood return verified and ports flushed. The 
catheter is secured and dressed. Post-procedural equipment verification is completed and an 
upright chest X-ray obtained.
3.1.3. Femoral vein catheterization
In the case of femoral vein catheterization, ultrasound can aid in anatomic visualization, how-
ever, the procedure is typically performed with anatomic landmarks only [2, 14]. The femo-
ral triangle is identified with superior border of the inguinal ligament, medial border of the 
adductor longus muscle and the lateral border of the sartorius muscle. Within the triangle, 
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the femoral vein is found medial to the common femoral artery, contained within the femo-
ral sheath. It is important to remember that the inguinal ligament runs between the anterior 
superior iliac spine and the pubic tubercle and does not necessarily correspond to the “groin 
crease” [1, 2].
The most advantageous patient positioning is with the hip in a neutral or slightly abducted 
and externally rotated. Unlike the SC or IJ approach, the patient is placed supine or in slight 
reverse Trendelenburg position. The insertion site is identified by locating the arterial pulsa-
tion 1–2 cm below the inguinal ligament within the femoral triangle. The needle insertion site 
is approximately 1 cm medial to this maximal pulsation and the axis of insertion is cephalad 
and medially towards the umbilicus at a 45° angle from the skin. The femoral vein is typically 
encountered 2–4 cm below the skin and is accessed below the level of the inguinal ligament. 
The modified Seldinger technique is again utilized; post-procedure imaging is not typically 
indicated [2].
3.1.4. Other considerations
Each insertion site has advantages and disadvantages; appropriate selection is affected by 
patient and clinical factors. The IJ can be accessed under direct visualization with ultra-
sound guidance and has a lower pneumothorax and hemothorax rate than the SC approach. 
However, it can be difficult in certain subsets of patients. Those with limited neck mobility, 
history of neck surgery, cervical collar, substantial subcutaneous tissue or significant cervical 
kyphosis can make IJ placement challenging [1, 14]. The SC has lower rates of arterial punc-
ture than femoral or IJ locations and the lowest infection rate of the three. The femoral site has 
the advantage of no hemothoraces or pneumothoraces. It is a relatively safe and accessible 
location which is typically distant from other monitoring devices and can be placed without 
interruption of intubation or cardiopulmonary resuscitation. Femoral catheterization allows 
for free motion of the upper extremities and neck. Despite this, it has the highest rate of infec-
tion, limits ambulation and has the highest risk of associated thrombus formation [2, 15].
For proper positioning of SC and IJ CVC, the distance between insertion site and the SVC-atrial 
junction is vital to appropriate positioning and the avoidance of inducing arrhythmias. In an 
American based prospective study, fluoroscopy was utilized to determine this distance. It was 
found that the distance for right IJ insertion averaged 16 cm, right SC averaged 18.4 cm, left 
IJ averaged 19.1 cm, and left SC 21.2 cm [23]. A South Korean retrospective review of patients 
with CVC who underwent chest CT revealed slightly shorter distances. They reported a right 
IJ of 15 cm, right SC 14 cm, left IJ 18 cm, and left SC 17 cm [24]. These distances should be con-
sidered when selecting and inserting a CVC to ensure appropriate placement.
3.2. Complications
There are numerous case reports and case series documenting the potentially devastating 
complications of CVC. These include bleeding events, arterial puncture, infective sequela, 
cardiac conduction abnormalities, catheter malposition, thrombotic events, and mechani-
cal device failure [1, 6, 25]. Identified risk factors for complications during CVC insertion 
are number of unsuccessful needle passes, inexperience of provider, body mass index >30 
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or <20, hypovolemia, large catheter size (specifically related to vascular complications), and 
previously failed catheterization attempts [1, 5, 25, 26]. When failed catheterization occurs, 
complications are reported as high as 28% [5]. Ultrasound assistance reduced immediate 
complications with the overall incidence decreased from 11.8 to 4–7% [5, 26]. In this section, 
the complications associated with CVC will be discussed briefly as well as advised action if 
they are encountered. The associated morbidity and mortality of these adverse events can be 
reduced with prompt recognition and appropriate action.
3.2.1. Bleeding events
Bleeding events include hemorrhage, hematoma, and hemothorax from arterial or venous 
injury. While uncommon, innominate, aortic, SVC, and right ventricular perforation are 
reported in the literature [25, 27–30]. In those cases, improper use of the dilator and guide-
wire kinking were cited as the cause for injury [5, 25, 27, 28]. More common, is injury from 
puncture or cannulation of the carotid, subclavian, common femoral, or external iliac artery. 
The incidence of arterial injury from puncture (≤18 G) is reported to be 4.2–9.3% and 0.1–1.0% 
from cannulation (>7 Fr.) [25]. The majority of these injuries are identified at the time of occur-
rence with recognition of blood coloration, pulsatile flow, ultrasound visualization, or pres-
sure measurements. If a needle puncture has occurred, it can typically be addressed with 
application of pressure. If the artery is cannulated, symptoms are reported in 30% of patients. 
In this subset, mortality reaches a rate of 20–40% [5]. Arterial catheter removal with direct 
pressure is associated with major complications in 47% of patients [31]. When removed by a 
surgical specialist or intervention radiologist under direct visualization with immediate sur-
gical or endovascular intervention a 0% complication rate is reported [31]. This disparity in 
outcomes prompted the recommendation that if arterial cannulation is suspected, leave the 
catheter in place and seek immediate surgical consultation [25, 29, 31].
Arterial cannulation can lead to hemorrhage/hematoma, neurologic deficits, pseudoaneu-
rysm, and AV fistula formation. Neurologic deficits are the result of either cerebral vascular 
ischemia or hematoma with nerve compression [5, 25, 31, 32]. Cerebral vascular ischemia from 
arterial CVC occurs when the inadvertent cannulation is not recognized and vasopressors are 
administered [5, 31]. Pseudoaneurysm and AV fistula formation can be an acute or delayed 
complication of arterial injury and discovery is reported years after catheterization [5]. The 
estimated incidence of AV fistula formation is 0.2% for IJ and 0.6% for SC catheterization 
attempts and can lead to symptomatic intracranial hypertension [5, 26]. Pseudoaneurysms 
are a recognized complication associated with arterial cannulation or rupture of a mediastinal 
vein during CVC placement [4, 33, 34]. The incidence of this rare complication is not defined 
in the literature. When a pseudoaneurysm does occur, treatment via endovascular stenting 
and open repair are described [4, 33]. Pseudoaneurysms can also occur with embolization 
following fracture of a catheter and in one case report resulted in a 5 × 4 cm pulmonary 
artery pseudoaneurysm which required surgical excision via lobectomy [33]. Both of these 
conditions require intervention. Various methods are described in the literature with coils, 
thrombin injections, manual compression, stenting, and open surgical approach utilized for 
repair [5, 26]. Once identified, the management of these complications should be undertaken 
with the aid of a vascular surgeon.
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Localized hematomas with nerve compression of the brachial plexus or the sympathetic trunk 
(causing Horner syndrome) occurs in 4.7% of all CVC. It is caused by either arterial or venous 
hemorrhage [5, 26]. Other complications which can arise from hematomas include vocal cord 
paralysis, phrenic nerve injury, respiratory distress and airway obstruction [5, 26]. Venous 
hematomas can arise from multiple punctures, venous laceration, and attempted access at an 
inappropriate site. The utilization of ultrasound or fluoroscopy is advocated for prevention of 
these complications [1, 6, 25].
Catastrophic hemorrhage is a surgical emergency which requires prompt recognition and 
action. It occurs in the acute setting from puncture or perforation into regions of large poten-
tial space including the thoracic, abdominal, and retroperitoneal cavities [5, 28, 35, 36]. Unlike 
the mediastinum or neck which has relatively limited space, these cavities can accommodate a 
large amount of blood without clinical signs until hemodynamic instability is reached. Similar 
to arterial cannulation, if this occurs or is suspected, the catheter should be left in place and 
a vascular or cardiothoracic consultation immediately obtained. In this case, the catheter is 
partially occluding the tract and removal of the catheter blindly can lead to increased hemor-
rhage and death. If circumstances allow, imaging studies to define the path of the catheter are 
obtained to aid in planning for its safe removal [5, 25, 36].
3.2.2. Central line-associated bloodstream infections (CLABSI)
Infective sequela of CVC has become an area of interest in recent years, particularly as the 
Centers for Medicare and Medicaid Services (CMS) withdrew reimbursement for the treat-
ment of hospital-acquired infections (HAI) including central line-associated bloodstream 
infections (CLABSI) [37]. The cause of CLABSI in non-tunneled CVC is attributed mainly to 
the migration of skin organisms at the insertion site through the cutaneous catheter tract and 
into the bloodstream with colonization of the external surface of the catheter. This modal-
ity of contamination is part of the rationale for tunneled CVC. Both non-tunneled and tun-
neled CVC contamination can occur via the catheter hub with intraluminal colonization of 
the catheters. Rarely, CVC can become seeded from other hematogenous infections [20, 38]. 
The infective organism encountered most frequently is Staphylococcus (37%), followed by 
Enterococcus [20, 22, 26, 38, 39]. The overall incidence of CLABSI is reported at 5.3 per 1000 
catheter days with a CDC estimated cost per infection of $16,550 and an attributed mortality 
of 18% [5, 26].
Higher rates of infection are noted based on entry site, emergent status of insertion, increased 
number of lumens, and type of CVC. With regards to location, PICC have the lowest infection 
rates of non-tunneled CVC at 1–2 per 1000 catheter days [20, 26, 38]. These are followed by SC 
(4 per 1000 catheter days) then IJ (8.6 per 1000 catheter days) and finally the femoral vein (15.3 
per 1000 catheter days) [5, 20, 22, 26, 38]. In the case of elective non-tunneled CVC, infection 
incidence is reported at 1.1–3.35 per 1000 catheter days, significantly lower than the reported 
overall infection rates [5, 20, 38]. The rate for tunnelled CVC is 1.3 per 1000 catheter days and 
for implanted ports is 0–1 per 1000 catheter days [20, 26].
In recent years, a number of guidelines emerged to aid in the safe insertion and utilization of 
CVC. These were prompted by the Michigan Keystone project published in 2006 by Pronovost 
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et al. which demonstrated significant reduction in CLABSI by implementing simple infection-
control practices [40]. These measures included maximum sterile barrier precautions, aseptic 
insertion technique, chlorhexidine skin preparation, transparent dressings, and removal of 
the catheter as soon as clinically possible [40–42]. It was also determined that the routine 
exchange of catheters for infection prevention was not necessary and may cause contamina-
tion [40, 42]. The increased interest and financial considerations have also led to device inno-
vations for infection reduction. These include alcohol impregnated caps for the covering of 
hubs, and the development of antimicrobial-impregnated CVC with both internal and exter-
nal surface impregnation [41, 42].
3.2.3. Cardiac arrhythmias and ectopy
Cardiac arrhythmias and ectopy are a recognized phenomenon during the placement of cen-
tral venous devices and are frequently observed with incidence reaching 75% when the guide-
wire is advanced 25–32 cm from the IJ entry site [5]. Occurrence rates during insertion of CVC 
in adult patients are 41% for atrial arrhythmias, and 25% for ventricular ectopy [43]. A slightly 
lower rate is reported for pediatric patients with a 30% overall incidence of arrhythmias [44]. 
While complications from these are rarely reported in the literature, malignant/fatal arrhyth-
mias have been described including complete heart block and sudden death. Typically these 
coincide with preexisting conduction abnormalities. In one such case report, a patient with a 
left bundle branch block was converted into a complete heart block during guidewire inser-
tion [3]. The suggested mechanism was the superficial location of the right bundle branch 
making it vulnerable to guidewire trauma [3].
Continuous cardiac monitoring should be utilized throughout CVC placement. If any ectopy 
or arrhythmia is identified, the guidewire should be withdrawn until it resolves completely. 
It is imperative that the provider is aware of the guidewire length. Guidewire insertion for the 
placement of a CVC should never exceed 18 cm and insertion of 14 cm should be adequate for 
all insertion sites [23, 24]. Late onset of arrhythmia is also reported with an incidence of 0.9% 
in indwelling tunneled or implanted port CVC [5]. These are typically responsive to removal 
or replacement of CVC. Another cause of delayed arrhythmia which must be considered is 
mediastinal or cardiovascular perforation which is the result of catheter malposition [6].
3.2.4. Catheter malposition and thrombosis
Catheter malposition occurs in 3.3% of CVC insertions with the highest incidence with right 
SC entry (9.1%) and least frequently with right IJ (1.4%) [45]. Catheter malposition into the 
innominate, left internal mammary, azygous, hemiazygos, lateral thoracic, inferior thyroid, 
intercostal, and thymic veins have occurred [46, 47]. Incorrect position can result in inaccurate 
hemodynamic monitoring, thrombosis, and arrhythmias [6, 45–47]. While a rare event, per-
foration is possible. CVC perforation without tamponade occurs at a rate of 0.4–1% with an 
associated mortality of 12%; the rate of perforation with subsequent tamponade is 0.2% with 
a mortality of 81–90% [5, 6]. These perforations are attributed to catheter malposition [5, 6]. 
The exact definition of catheter malposition has evolved over the years but today is accepted 
as placement within the heart, an angle of incidence (the angle between the CVC tip and the 
wall of the vein) >40°, and placement into vessel other than the SVC or IVC [5].
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The ideal catheter position for SC and IJ is with the tip in the SVC just above the right atrial 
junction. The accepted corresponding surface landmarks are the angle of Louis (the junction 
between the manubrium and sternum) or the right sternal border of the third intercostal space 
[1, 12, 15]. These can be used to estimate the appropriate length of catheter for insertion but 
final positioning should always be confirmed with a chest X-ray or fluoroscopy. The most reli-
able radiography landmark for placement verification is the CVC tip at the right tracheobron-
chial angle which ensures it lays ≥3 cm above the pericardial reflection [5]. This is accurate 
even when patient positioning gives the appearance of the CVC within the cardiac silhouette.
CVC thrombotic events are site, catheter, and patient dependent. In the case of non-tunneled 
CVC, site appears to be the major determining factor with the highest incidence occurring at 
the femoral site (21.5–29%) and lowest at the SC site (1.9%) [1, 6]. Catheter-related thrombosis in 
tunneled and indwelling port CVC has a reported incidence of 33–59% with a SVC obstruction 
rate of 0.1% [5]. Patients with malignancies are at particularly high risk for thrombus formation 
with an incidence of 41%; 15–30% of these patients will be symptomatic and 11% will experi-
ence an associated pulmonary embolism [5]. Anticoagulation and thromboprophylaxis was 
studied in this subset of patients without evidence of prevention or benefit [5]. Efforts to reduce 
the thrombogenicity of the catheter materials have been ongoing for >30 years [48–50]. This led 
to the refinement of materials with recognition that polyethylene catheters have a higher inci-
dence of thrombus while silicone and polyurethane exhibit improved biocompatibility [49, 51]. 
Newer efforts have investigated the application of an athrombogenic layer, impregnation of 
catheter with medications including heparin and nitric oxide, as well as improved composition 
of catheter materials [51–53]. Due to the interaction between the catheter surface and hematog-
enous components, thrombus formation can occur at any point along the device. Morbidity 
from thrombus formation includes embolic events (particularly if the thrombus is associated 
with the tip of the catheter or >3 cm), infected thrombus, SVC occlusion, and ipsilateral edema 
[6, 54–57]. If a thrombus is identified and is <3 cm, the CVC can be safely removed without evi-
dence of adverse events. However, if >3 cm there is an increased risk of embolic event upon line 
removal; anticoagulation or thrombolytic therapy is utilized to reduce the thrombus size but 
surgical removal is sometimes necessary [26]. In the event of thrombus identification, therapy 
should include symptomatic management, determination of the continued need to catheter-
ization, monitoring for propagation and anticoagulation or thrombolytic therapy if indicated.
3.2.5. Mechanical failure
The mechanical failure of equipment is a potential complication of any device. Immediate mechan-
ical failure is generally related to guidewire issues including retention from looping, entrapment, 
wedging within the catheter and fracture during insertion [9–11]. Cases of wire and catheter 
entrapment within inferior vena cava (IVC) filters, knotting with existing CVC, and incorporation 
with cardiac sutures are reported [26]. These have been managed with fluoroscopic endovascular 
procedures but at times require surgical intervention [11, 26]. When identified, immediate cor-
rection is preferred in stable patients. Known complications include catheter fragmentation with 
distal embolization and access site injury [26, 58]. The available literature on these cases is limited.
During insertion, guidewire fracture risk can be minimized by careful attention to associated resis-
tance. If resistance is encountered, it may be from extraluminal placement, kinking, entrapment, or 
Vignettes in Patient Safety - Volume 2160
intraluminal stenosis [8, 25, 47, 58, 59]. When this occurs, remove the needle and guide wire en bloc 
(together), inspect immediately to verify complete removal, obtain new equipment and reinitiate 
procedure [12, 15, 16]. In this way, wire fracture and embolization is avoided. If you continue to 
encounter resistance, an alternative insertion site or fluoroscopic guidance should be considered.
Delayed mechanical failure is more commonly encountered with catheter fracture and embo-
lization occurring in 0.5–3% of indwelling CVC with a morbidity rate of 71% and mortality 
of 30–38% [5]. Arrhythmia, cardiac arrest, pulmonary embolism with hemoptysis, perfora-
tion, and thrombosis are reported. Causes of delayed failure include breakage during catheter 
removal, entrapment, material properties of the catheter, and long-term mechanical fatigue 
[60, 61]. Material analysis from fractured catheters has shown an increased fracture risk with 
silicone catheters compared to polyurethane [60, 61]. Additionally, fatigue is particularly 
prevalent in SC catheters where mechanical shearing between the clavicle and first rib can 
occur [2, 5, 62]. This is referred to as pinch-off syndrome and is characterized by functional 
occlusion with postural changes. It will be reported by patients and staff as an inability to 
aspirate and difficultly flushing the catheter which is improved when the arm is raised. When 
pinch-off syndrome occurs, the repeated shear stress on the catheter will eventually cause 
fracture and embolization [2, 5, 62]. It is estimated that pinch-off syndrome is responsible for 
41% of catheter embolic events and should be addressed immediately upon identification [2].
3.3. Foreign body retrieval
Retained intravascular foreign bodies can occur during a variety of procedures. With the rap-
idly expanding scope of endovascular interventions, this complication will continue to be of 
clinical significance. In the case of CVC, guidewire retention during insertion is estimated at a 
rate of 0.03–0.1%, catheter retention during removal is estimated at 1.5%, and the overall inci-
dence of retained foreign body due to CVC is reported between 0.3 and 1.5% [63–65]. Reports 
of CVC retention and recovery are presented in case reports, case series and retrospective 
reviews. These often pool the identification and recovery of all intravascular foreign objects. 
Embolization is common with identification in the venous system (46%), right heart (35%), 
and pulmonary arterial system (19%). The reported cases occur both immediately following 
procedures and with indwelling devices. In the case of procedure related retention, delayed 
identification of the foreign body is reported in 54% of cases, with the longest time to iden-
tification reported at 6 weeks [10]. Since post-procedure imaging often fails to demonstrate 
a retained object, the true incidence may be higher than reported. When an intravascular 
foreign object is identified, they are symptomatic in 5.6% of cases and an incidental finding 
on unrelated imaging in 37% of cases [64]. When identified, endovascular retrieval is the pre-
ferred method of recovery due to its minimally invasive approach [5, 9–11, 64, 66].
Endovascular retrieval methods have substantially improved since first reported by Thomas et 
al in 1964 [67]. Approaches for endovascular retrieval include fluoroscopic, CT, ultrasound, and 
rarely MRI guided retrieval [9]. Retrieval devices include a variety of loop snares, intravascular 
retrieval forceps, and retrieval baskets [9, 11, 64, 66]. A recovery rate of 86.6–94% is reported 
[64, 66]. One case series noted that two thirds of the non-retrieved items were related to CVC 
[64]. Interestingly, the rate of failed retrieval in case reports is 14.4% while only 3.7% in case 
series, suggesting publication bias is likely prevalent [66]. Proposed relative contraindications 
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to recovery include small fragment size, difficult to access location, predicted potential for sub-
sequent complication, patient’s clinical status, and associated symptoms [64, 66].
Complication rates associated with retained intravascular foreign bodies vary substantially. In 
the pediatric literature, Chan et al described no complications in a case series of four retained 
CVC in pediatric patients with a median follow up of 7.5 months (range 1–53 months). Within 
the international literature, they noted an overall retention rate of 48.6% with no major com-
plications reported [63]. When retention and embolism occurs in the adult literature, the rate 
of major complication is 71%. Major complications include persistent infection with sepsis, 
thrombosis, vascular occlusion, and migration into surrounding structures [63, 64, 66, 68–70]. 
Bacterial contamination is noted in 28% of these patients. Overall mortality associated with all 
intravascular foreign bodies ranges between 24 and 60% whereas the mortality rate specific to 
CVC related events is estimated to be much lower at 1.8% [64, 66, 71].
Attempts to identify complication risk factors and implement appropriate preventive mea-
sures prompted a recent study of intravenous retained surgical items (ivRSI) spanning 6 years 
[10]. In this multicenter study, 13 ivRSI were identified. Risk factors associated with ivRSI 
were unexpected procedural factors and equipment failure. Unexpected procedural factors 
were defined as blood loss >500 mL, technically difficult procedure, lack of familiarity with 
equipment, and difficult/emergent setting. Equipment failure included any documented mal-
function/breakage of instrument, hardware, wire, or catheter during the procedure. While 
this study was specific to endovascular procedures, similar risk factors can be anticipated in 
bedside procedures (Figure 2).
Figure 2. CT-chest revealing a retained guidewire within right atrium (arrow). This was removed under local anesthetic 
with fluoroscopic guidance via an 8 Fr. right IJ sheath with a 2.5 cm loop snare and guiding catheter.
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4. Conclusion
Central venous catheters represent an important clinical adjunct. Their utilization for the 
delivery of life saving therapies continues to expand. The complications discussed represent 
the most frequently reported and potentially devastating complications. With more than 15 
million central venous catheter days yearly in the US, it is likely that providers will encounter 
complications [26]. Identified risk factors include number of unsuccessful needle passes, inex-
perience of provider, body mass index >30 or <20, hypovolemia, large catheter size and previ-
ously failed catheterization attempts [1, 5, 25, 26]. As a provider it is necessary to have a basic 
knowledge of complication management. Prompt action reduces the morbidity and mortality. 
In the case of a retained guide wire or embolized fragment, immediate retrieval is indicated.
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